Moleculin Biotech, Inc. (MBRX)
NASDAQ: MBRX · Real-Time Price · USD
4.050
+0.070 (1.76%)
At close: Jan 12, 2026, 4:00 PM EST
4.110
+0.060 (1.48%)
After-hours: Jan 12, 2026, 7:45 PM EST
Moleculin Biotech Market Cap
Moleculin Biotech has a market cap or net worth of $12.47 million as of January 12, 2026. Its market cap has increased by 139.82% in one year.
Market Cap
12.47M
Enterprise Value
6.16M
1-Year Change
139.82%
Ranking
Category
Stock Price
$4.05
Market Cap Chart
Since June 2, 2016, Moleculin Biotech's market cap has decreased from $70.70M to $12.47M, a decrease of -82.36%. That is a compound annual growth rate of -16.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 8.10M | 20.90% |
| Dec 31, 2025 | 6.70M | 31.37% |
| Dec 31, 2024 | 5.10M | -80.08% |
| Dec 29, 2023 | 25.60M | -15.51% |
| Dec 30, 2022 | 30.30M | -43.05% |
| Dec 31, 2021 | 53.20M | 6.83% |
| Dec 31, 2020 | 49.80M | 19.14% |
| Dec 31, 2019 | 41.80M | 48.23% |
| Dec 31, 2018 | 28.20M | -28.24% |
| Dec 29, 2017 | 39.30M | 42.91% |
| Dec 30, 2016 | 27.50M | -61.10% |
| Jun 2, 2016 | 70.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.29B |
| Johnson & Johnson | 492.44B |
| AbbVie | 388.97B |
| UnitedHealth Group | 311.59B |
| AstraZeneca | 295.57B |
| Merck & Co. | 274.34B |
| Novartis AG | 272.98B |
| Novo Nordisk | 263.81B |